Published online before print April 10, 2008

This Article Full Text (Rapid PDF) Supplemental Material All Versions of this Article: ajpath.2008.071117v1 172/5/1248    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arad, S. Articles by Gilchrest, B. A. Search for Related Content PubMed PubMed Citation Articles by Arad, S. Articles by Gilchrest, B. A.

Copyright © 2008 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2008.071117

Accepted for publication February 5, 2008.

Article

Topical Thymidine Dinucleotide Treatment Reduces Development of Ultraviolet-Induced Basal Cell Carcinoma in Ptch-1^+/- Mice

Simin Arad^*, Edoardo Zattra^*, Jennifer Hebert, Ervin H. Epstein Jr., David A. Goukassian^*@, and Barbara A. Gilchrest^*@

From the Department of Dermatology,* Boston University School of Medicine, Boston, Massachusetts; and the Children's Hospital of Oakland Research Institute, Oakland, California

^@ To whom correspondence should be addressed. E-mail: dgoukass{at}bu.edu.

	Abstract

Treatment with thymidine dinucleotide (pTT) has well documented DNA-protective effects and reduces development of squamous cell carcinoma in UV-irradiated mice. The preventive effect of pTT on basal cell carcinoma (BCC) was evaluated in UV-irradiated Ptch-1^+/- mice, a model of the human disease Gorlin syndrome. Topical pTT treatment significantly reduced the number and size (P < 0.001) of BCCs in murine skin after 7 months of chronic irradiation. Skin biopsies collected 24 hours after the final UV exposure showed that pTT reduced the number of nuclei positive for cyclobutane pyrimidine dimers by 40% (P < 0.0002) and for 8-hydroxy-2'-deoxyguanosine by 61% (P < 0.01 compared with vehicle control). Immunostaining with an antibody specific for mutated p53 revealed 63% fewer positive patches in BCCs of pTT-treated mice compared with controls (P < 0.01), and the number of Ki-67-positive cells was decreased by 56% (P < 0.01) in pTT-treated tumor-free epidermis and by 76% (P < 0.001) in BCC tumor nests (P < 0.001). Terminal dUTP nick-end labeling staining revealed a 213% increase (P < 0.04) in the number of apoptotic cells in BCCs of pTT-treated mice. Cox-2 immunostaining was decreased by 80% in tumor-free epidermis of pTT-treated mice compared with controls (P < 0.01). We conclude that topical pTT treatment during a prolonged period of intermittent UV exposure decreases the number and size of UV-induced BCCs through several anti-cancer mechanisms.

This article has been cited by other articles:

				A. Honda, R. Abe, Y. Yoshihisa, T. Makino, K. Matsunaga, J. Nishihira, H. Shimizu, and T. Shimizu Deficient deletion of apoptotic cells by macrophage migration inhibitory factor (MIF) overexpression accelerates photocarcinogenesis Carcinogenesis, September 1, 2009; 30(9): 1597 - 1605. [Abstract] [Full Text] [PDF]